Bath & Body Works, Inc. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD from Q4 2009 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
Bath & Body Works, Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q4 2009 to Q3 2024.
  • Bath & Body Works, Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending November 2, 2024 was $200M, a 1.52% increase year-over-year.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $200M +$3M +1.52% Nov 2, 2024 10-Q 2024-11-26
Q2 2024 $146M -$7M -4.58% Aug 3, 2024 10-Q 2024-08-28
Q1 2024 $121M -$24M -16.6% May 4, 2024 10-Q 2024-06-04
Q4 2023 $224M -$2M -0.89% Feb 3, 2024 10-Q 2024-11-26
Q3 2023 $197M -$45M -18.6% Oct 28, 2023 10-Q 2024-11-26
Q2 2023 $153M -$31M -16.8% Jul 29, 2023 10-Q 2024-08-28
Q1 2023 $145M -$22M -13.2% Apr 29, 2023 10-Q 2024-06-04
Q4 2022 $226M -$14M -5.83% Jan 28, 2023 10-K 2024-03-22
Q3 2022 $242M $0 0% Oct 29, 2022 10-Q 2023-12-01
Q2 2022 $184M +$53M +40.5% Jul 30, 2022 10-Q 2023-09-01
Q1 2022 $167M +$57M +51.8% Apr 30, 2022 10-Q 2023-06-02
Q4 2021 $240M +$92M +62.2% Jan 29, 2022 10-K 2023-03-17
Q3 2021 $242M +$81M +50.3% Oct 30, 2021 10-Q 2022-11-30
Q2 2021 $131M -$137M -51.1% Jul 31, 2021 10-Q 2022-09-02
Q1 2021 $110M -$119M -52% May 1, 2021 10-Q 2022-06-02
Q4 2020 $148M -$158M -51.6% Jan 30, 2021 10-K 2022-03-18
Q3 2020 $161M -$134M -45.4% Oct 31, 2020 10-Q 2021-12-03
Q2 2020 $268M -$15M -5.3% Aug 1, 2020 10-Q 2021-09-02
Q1 2020 $229M -$45M -16.4% May 2, 2020 10-Q 2021-06-03
Q4 2019 $306M -$61M -16.6% Feb 1, 2020 10-K 2021-03-19
Q3 2019 $295M -$26M -8.1% Nov 2, 2019 10-Q 2020-12-04
Q2 2019 $283M -$27M -8.71% Aug 3, 2019 10-Q 2020-09-03
Q1 2019 $274M $0 0% May 4, 2019 10-Q 2020-06-03
Q4 2018 $367M +$57M +18.4% Feb 2, 2019 10-K 2020-03-30
Q3 2018 $321M +$36M +12.6% Nov 3, 2018 10-Q 2019-12-06
Q2 2018 $310M +$65M +26.5% Aug 4, 2018 10-Q 2019-09-06
Q1 2018 $274M +$61M +28.6% May 5, 2018 10-Q 2019-06-04
Q4 2017 $310M +$16M +5.44% Feb 3, 2018 10-K 2019-03-22
Q3 2017 $285M -$40M -12.3% Oct 28, 2017 10-Q 2018-12-04
Q2 2017 $245M -$21M -7.9% Jul 29, 2017 10-Q 2018-09-07
Q1 2017 $213M -$36M -14.5% Apr 29, 2017 10-Q 2018-06-07
Q4 2016 $294M +$33M +12.6% Jan 28, 2017 10-K 2018-03-23
Q3 2016 $325M +$42M +14.8% Oct 29, 2016 10-Q 2017-12-01
Q2 2016 $266M +$9M +3.5% Jul 30, 2016 10-Q 2017-09-01
Q1 2016 $249M +$10M +4.18% Apr 30, 2016 10-Q 2017-06-02
Q4 2015 $261M +$9M +3.57% Jan 30, 2016 10-K 2017-03-17
Q3 2015 $283M +$9M +3.29% Oct 31, 2015 10-Q 2016-12-02
Q2 2015 $257M +$24M +10.3% Aug 1, 2015 10-Q 2016-09-02
Q1 2015 $239M +$23M +10.6% May 2, 2015 10-Q 2016-06-03
Q4 2014 $252M +$8M +3.28% Jan 31, 2015 10-K 2016-03-18
Q3 2014 $274M +$29M +11.8% Nov 1, 2014 10-Q 2015-12-04
Q2 2014 $233M +$36M +18.3% Aug 2, 2014 10-Q 2015-09-04
Q1 2014 $216M +$41M +23.4% May 3, 2014 10-Q 2015-06-05
Q4 2013 $244M +$41M +20.2% Feb 1, 2014 10-K 2015-03-20
Q3 2013 $245M +$20M +8.89% Nov 2, 2013 10-Q 2014-12-05
Q2 2013 $197M +$22M +12.6% Aug 3, 2013 10-Q 2014-09-05
Q1 2013 $175M +$17M +10.8% May 4, 2013 10-Q 2014-06-06
Q4 2012 $203M -$15M -6.88% Feb 2, 2013 10-K 2014-03-21
Q3 2012 $225M -$73M -24.5% Oct 27, 2012 10-Q 2013-12-06
Q2 2012 $175M -$66M -27.4% Jul 28, 2012 10-Q 2013-09-06
Q1 2012 $158M -$47M -22.9% Apr 28, 2012 10-Q 2013-06-07
Q4 2011 $218M -$14M -6.03% Jan 28, 2012 10-K 2013-03-22
Q3 2011 $298M +$51M +20.6% Oct 29, 2011 10-Q 2012-11-30
Q2 2011 $241M +$32M +15.3% Jul 30, 2011 10-Q 2012-08-31
Q1 2011 $205M +$6M +3.02% Apr 30, 2011 10-Q 2012-06-01
Q4 2010 $232M +$13M +5.94% Jan 29, 2011 10-K 2012-03-23
Q3 2010 $247M Oct 30, 2010 10-Q 2011-12-02
Q2 2010 $209M Jul 31, 2010 10-Q 2011-08-31
Q1 2010 $199M May 1, 2010 10-Q 2011-06-03
Q4 2009 $219M Jan 30, 2010 10-K 2011-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.